Skip to content

COmparison of iN situ structural integrity of TrAnsCatheter Heart Valves

COmparison of iN situ structural integrity of TrAnsCatheter Heart Valves - CONTACT study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40932
Enrollment
60
Registered
2014-06-10
Start date
2014-05-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

function and durability of aorticvalve Structural integrity of transcatheter heart valve

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All Patients who undergo TAVI with the following THV are eligible for this study: 1. Medtronic Corevalve 2. Edwards Sapien and Sapien 3 3. BSC Lotus 4. St Jude Portico 5. Jenavalve THV 6. Direct Flow

Exclusion criteria

Exclusion criteria: Exclusion criteria 1) GFR

Design outcomes

Primary

MeasureTime frame
Primary Objective: MSCT and rotational angiography protocol is used to assess: o Identify fractures in the framework o Determine diameter of THV inflow, outflow and valve functioning segment and assess circularity o Determine Inflow and constraint segment perimeter and area o Aortic root -THV relationship: circularity index of aortic root and THV

Secondary

MeasureTime frame
Secondary Objective: o Transprosthetic gradient as assessed by Doppler TTE o (paravalvular) aortic regurgitation by Doppler TTE o Assess LV diameters/volumes

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)